Gerhard Müller-Newen

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Extracellular Matrix

Prostate Cancer

Top Venues

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Piotr Topolewski, Karolina E Zakrzewska, Jarosław Walczak, Karol Nienałtowski, Gerhard Müller-Newen, Abhyudai Singh, Michał Komorowski
Phenotypic variability, not noise, accounts for most of the cell-to-cell heterogeneity in IFN-γ and oncostatin M signaling responses. Science signaling 15 (721) (2022)
Cristina Maranto, Vindhya Udhane, Jing Jia, Ranjit Verma, Gerhard Müller-Newen, Peter S LaViolette, Michaela Pereckas, Lavannya Sabharwal, Scott Terhune, Nagarajan Pattabiraman, Vincent C O Njar, John D Imig, Liang Wang, Marja T Nevalainen
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. Cancers 12 (11) (2020)
Sabrina Ernst, Gerhard Müller-Newen
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention? Cancers 11 (11) (2019)
Maja Kim Kuepper, Marlena Bütow, Oliver Herrmann, Janine Ziemons, Nicolas Chatain, Angela Maurer, Martin Kirschner, Tiago Maié, Ivan G Costa, Jörg Eschweiler, Steffen Koschmieder, Tim H Brümmendorf, Gerhard Müller-Newen, Mirle Schemionek
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling. Leukemia 33 (8) (2019)